Marcia Belvin, SVP, Chief Scientific Officer: CytomX Therapeutics CTMX Sell · Filed 23/12/22

Trade details

Type: Insider sale
Amount: $5,626.26
Shares · price: 4,077 sh · $1.38 a share
Held after: 155,124 sh
Stock: CytomX Therapeutics CTMX
Person: Marcia BelvinSVP, Chief Scientific Officer
Trade date: 23/12/20
Filed: 23/12/22
Days to filing: 2 days

Sold 2.6% of holdings

Share of holding sold: 2.6%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/20~24/01/19

Marcia Belvin's recent trades

Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$202.2K
31,492 sh
$202.2K
Filed 03/19
Traded 03/17
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$37.3K
13,884 sh
$37.3K
Filed 25/06/17
Traded 25/06/16
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$11.7K
19,512 sh
$11.7K
Filed 25/03/20
Traded 25/03/18
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Marcia BelvinSVP, Chief Scientific Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$26.7K
12,795 sh
$26.7K
Filed 24/03/21
Traded 24/03/19

Marcia Belvin, Chief Officer — sold $5,626 of CytomX Therapeutics CTMX · 2.6% of holdings | Whalegun